H Gögelein1. Show Affiliations » 1. Aventis Pharma Deutschland GmbH, DG Cardiovascular Diseases, Frankfurt/Main, Germany. heinz.goegelein@aventis.com
Abstract
Entities: Chemical
Mesh: See more » Adenosine Triphosphate/pharmacologyAnimalsBenzamides/pharmacologyHeart/drug effectsHumansPotassium Channel BlockersPotassium Channels/analysisSulfonylurea Compounds/pharmacology
Substances: See more » BenzamidesPotassium Channel BlockersPotassium ChannelsSulfonylurea CompoundsAdenosine TriphosphateHMR 1098
Year: 2001 PMID: 11527016
Source DB: PubMed Journal: Curr Opin Investig Drugs ISSN: 1472-4472